19Juin

Intravenous UC-MSCs for Ischemic Stroke: What the MERIT Phase 1 Trial Tells Us

The MERIT phase 1 trial published in Cell Reports Medicine shows that intravenous UC-MSC therapy is safe in subacute ischemic stroke, with early NIHSS improvement signals. Here’s what clinicians need to know.

MSC, Cellules souches, Stroke, , , , , , , 0 Commentaires
Lire la suite...
17Fév

Stem Cell Therapy ‘Jump-Starts’ Brain Repair After Stroke: A New Era in Neurological Recovery

Imagine a world where the devastating effects of a stroke could be reversed, even weeks after the event. This isn’t science fiction—it’s the promising reality emerging from groundbreaking research in stem cell therapy. A recent study has shown that stem cell treatment can effectively ‘jump-start’ brain repair processes, offering new...

Cellules souches, Stroke0 Commentaires
Lire la suite...
Top